Jeff Stafeil
Analyst · Bank of America. Your line is now open
Great. Thanks, Doug. Good morning everyone. Let's jump into Adient's Q4 financial results on Slide 13. Adhering to our typical format, the page is formatted with our reported results on the left and our adjusted results on the right-hand side of the page. We will focus our commentary on the adjusted results, which excludes special items that we view as either onetime in nature or otherwise skew important trends and underlying performance. For the quarter, the biggest drivers of the difference between our reported and our adjusted results relate to a gain in the sale of our unconsolidated partially owned affiliate YFAS and an associated derivative loss in the forward contract used to lock in the exchange rate on the transaction proceeds. Other adjustments related to pension mark-to-market adjustments purchase accounting amortization restructuring and transaction costs. Details of all the adjustments for the quarter and the full-year are in the appendix of the presentation. High level for the quarter sales were $2.8 billion down about 23% compared to our fourth quarter results last year. The most recent quarter was specifically, impacted by lost production, primarily driven by supply chain disruptions related to semiconductors. Adjusted EBITDA for the quarter was $118 million down $169 million in a year-on-year a decrease in volume and mix numerous temporary operating inefficiencies driven from the challenging operating environment drove the decrease. I'll expand on these key drivers in just a minute. Finally at the bottom line, Adient reported an adjusted net loss of $23 million or a loss of $0.24 per share. Note that our GAAP net income, was $950 million driven by the completion of the China transaction. Slide 14 provides a similar high-level summary of Adient's full year key financial metrics. As Doug mentioned earlier, the full year results can be best summarized as a tale of two halves: strong first half performance with significant year-over-year earnings and margin improvement. Adient's second half results significantly -- were significantly impacted by the overall macro environment, customer production disruptions and rising commodity prices. For the year, sales were $13.7 billion, up 8% compared to last year. Adjusted EBITDA was $917 million, up $244 million compared with the COVID impacted results in fiscal 2020. You can see, we noted the EBITDA margin, excluding equity income, commodity headwinds and temporary operating inefficiencies, would have been greater than 6%, even with an abnormally low sales level. We see this as clear evidence that the company continues to execute well on items within its control. And at the bottom line, net income of $199 million compared to a net loss of $4 million in 2020. Within the outlook section of this presentation, we've provided a full year revenue and adjusted EBITDA walk from the reported results to a pro forma 2021 view. The pro forma view essentially accounts for all of the portfolio adjustments made throughout the year and should help with the walk to our 2022 expectations. More on this in a minute. Now let's break down our fourth quarter results in more detail. I'll cover the next few slides rather quickly, as detailed for the results are included on the slides and this should ensure we have an adequate amount of time set aside to review Adient's expectations for 2022. Starting with revenue on slide 15. We reported consolidated sales of $2.8 billion, a decrease of $826 million compared to the same period a year ago. The primary driver of the year-over-year decrease was due to lower volume, call it just over $800 million. Portfolio adjustments impacted the quarter by about $35 million. These negative headwinds were partially offset by approximately $17 million due to FX movements. Focusing on the table on the right-hand side of the slide, you can see our consolidated sales generally kept pace with production in both Americas and EMEA. In Asia, Adient experienced outperformance versus the market, driven by our customer and content mix specifically in Japan and Thailand. In China, the underperformance was driven primarily by certain of our customers, such as Daimler, that were more heavily impacted by semiconductor shortages. Of course, we view this as temporary and should reverse as supply chain stabilize. With regard to Adient's unconsolidated seating revenue, year-over-year results were down about 10% adjusting for FX and executed portfolio changes. The performance was better than the market in China, primarily driven by positive mix at YFAS. Moving to slide 16. We've provided a bridge of adjusted EBITDA to show the performance of our segments between periods. The bucket labeled corporate represents central costs that are not allocated back to the operation such as executive office, communications, corporate finance and legal. Big picture, adjusted EBITDA was $118 million in the current quarter versus $287 million last year. The primary drivers of the decrease are detailed on the page. Simply put, the quarter was down over 20% in volume, but the impact was exacerbated by numerous abrupt and last-minute adjustments to production schedules at our customers, which continued to drive inefficiencies in our operations. In addition, similar to our third quarter, elevated commodity prices also pressured earnings. The significant headwinds were partially offset by improved core business performance, such as lower launch costs, ops waste and improved net material margin. SG&A was favorable year-over-year by $41 million, primarily driven by adjustments to performance-based compensation and the net impact of accrual true-ups. In summary, SG&A for the year is representative of our spend, but our Q4 level is lower than we'd expect on an ongoing basis. I do not plan to go into a detailed discussion of this page, but we've outlined the movements year-over-year in detail for your information. Important to note, although, the macro pressures which are largely out of Adient's control significantly impacted our Q4 and second half results. The team is not sitting idle. We're continuing to execute actions to improve our business performance and reduce our cost base. Similar to past quarters, we've provided our detailed segment performance slides in the appendix of the presentation, high level for Americas and EMEA, improved ongoing business performance and lower SG&A costs were more than offset by the impact of lower volume, the negative impact of temporary operating inefficiencies and elevated commodity costs. In Asia, the benefits of slightly higher volumes lower SG&A and improved business performance modestly outweighed the negative impact of temporary operating inefficiencies and the negative impact of portfolio adjustments. Let me now shift to our cash liquidity and capital structure on slide 17 and 18. Starting with cash on slide 17. I'll focus on full year results as the longer time frame helps smooth some of the volatility in working capital movements. Adjusted free cash flow defined as operating cash flow less CapEx was breakeven for the year. This compares to a cash outflow of about $80 million in 2020. The year-on-year improvement was partially driven by higher earnings, increased dividends from our China operations underpinned by the agreements related to our strategic transformation and lower capital expenditures. These benefits were offset -- were partially offset by an increase in restructuring nearly $300 million increase in inventory balances and an increase in VAT payments, and finally, the timing of commercial settlement activities. The VAT payments as mentioned throughout 2021 are larger than normal in 2021 and relate to government-approved delays out of 2020 due to COVID accommodations. Just a few comments related specifically to 2021. Restructuring was elevated at approximately $150 million. We'd expect that trend to trend back to closer to $100 million or perhaps inside of that in the coming years. Inventory trended higher as we secured commodities and other components to prevent disruptions to our customers bought extra supply due to pending increases in commodity prices and overall experienced higher commodity prices than a year ago. And finally, capital expenditures were lower than expected as customer launches were pushed from fiscal 2021 to 2022 and the team continues to find ways to increase our capital utilization. Flipping to slide 18. As noted on the right-hand side of the slide, we ended the quarter with about $2.8 billion of total liquidity comprised of cash on hand of about $1.5 billion and approximately $740 million of undrawn capacity under Adient's revolving line of credit. Also noted, the September 30 cash balance includes approximately $695 million in proceeds from the China transaction. Final after-tax proceeds of about $625 million are expected prior to calendar year end. Adient's debt and net debt position totaled $3.7 billion and $2.2 billion, respectively at September 30. As Doug mentioned earlier, significant progress was made throughout the year to transform the company's capital structure. Since September 2020, we were paid approximately $100 million of the 4, 7 8's unsecured notes fully repaid the $800 million, 7% first lien notes and repaid approximately $40 million of our EIB loan. And in addition, we opportunistically amended and extended our term loan. Given our cash balance and the additional proceeds from the China transaction that are expected prior to year end, we expect to continue our deleveraging efforts as we progress through fiscal 2022. Clearly the transformation of Adient's balance sheet is solidly on track. With that let's flip to slide 20 through 23 and review our outlook for fiscal 2022. To begin with the persistent macro headwinds primarily supply chain disruptions and inflationary pressures on such things as commodities, freight, energy et cetera are expected to have a significant impact on the industry and Adient in fiscal 2022. On the right-hand side of slide 20, we've laid out our planning assumptions for production and FX compared with fiscal 2021. The foundation of our fiscal 2021 plan is generally aligned with the October IHS estimates with limited overlays for known customer release schedules. As you know the current operating environment is very fluid, visibility into the production is cloudy at best, supply chain disruptions and resulting production stoppages could result in significantly different outcomes. To emphasize the point, many of our customers continue to project volume far in excess of IHS volumes that we're using thus requiring us to staff our operations with more headcount than what is implied by our projections. This creates a higher-than-normal decremental margin impact if the IHS volumes turn out to be correct. As Doug mentioned earlier, our current expectations assume global vehicle production will be about flat for Adient's fiscal year up in Americas and EMEA and down in Asia. The production forecast is expected to result in a mixed headwind in fiscal '22, given that our higher-margin business in Asia is down or projected to be down. I'd also point out that in Europe despite overall production trending higher Adient sales are forecast to be modestly lower as we expect the impact of the microchip shortage to disproportionately impact our business similar to what we experienced in 2021. Now I'll review our -- how these assumptions impact our '22 outlook beginning with sales on Slide 21. At the top of the slide, we've included a bridge that walks our fiscal 2021 sales of $13.7 billion to our pro forma 2021 sales of $14.3 billion. The pro forma sales reflect the impact of portfolio adjustments executed throughout the year. Over the last two years, we have done a fair amount of portfolio rearrangement as part of our back-to basics strategy. Some of the changes were quite big while others were relatively small. In addition, some of the moves are very recent. So, we pulled together our pro forma view of 2021 to help you understand the total impact. As you can see the China strategic transaction adds roughly $870 million to our consolidated sales. Small divestitures in China have a leftover piece of our fabrics business and some entities obtained through the Futuris acquisition reduced pro forma sales by approximately $120 million. Note that these small divestitures represented businesses where we had not won nor did we expect to win replacement business and thus had fairly immaterial proceeds. We recently sold our interest in a metals operation in Turkey to an unconsolidated JV we have in the same country. This will impact our consolidated sales by about $100 million. Other minor footprint actions across EMEA and Americas total about $50 million and primarily related to small plant closures for business that was running off. Bottom line if these transactions that happened at the beginning of fiscal 2021, Adient's consolidated sales would have been about $14.3 billion versus the $13.7 billion reported. Now walking the $14.3 billion to our forecast for fiscal '22. Volume net new business the impact of commercial and commodity recoveries and FX are expected to provide tailwinds, but partially offsetting the positive influences are customer pricing headwinds. In the end based on the current environment and the positive and negative influences we're forecasting fiscal '22 consolidated sales of about $14.8 billion. Turning to Slide 22. We've also included a high-level bridge illustrating our expectations for adjusted EBITDA. Similar to sales we've provided a pro forma walk at the top. Key drivers include the impact of the China strategic transaction which benefits consolidated EBITDA by about $90 million and reduces equity income by roughly $155 million. This impact to equity income is slightly higher versus our original estimate due to better-than-expected performance at YFAS in the fourth quarter. The other China transactions namely the leftover piece of our fabrics business some entities obtained through the Futuris acquisition and the impact of Adient selling its 50% equity interest in its SJA joint venture which was announced concurrently with the China strategic transaction will impact EBITDA in total by about $15 million. The EMEA JV deconsolidation will decrease consolidated EBITDA by $20 million partially offset by an increase in equity income of about $5 million. Proceeds related to this transaction will total about $50 million, $40 million of which was collected on October 1. The $50 million in total proceeds reflect the unique challenges to this operation relating to winning and launching the replacement business in Turkey. The footprint actions in EMEA and Americas primarily represent several small operations that were closed due to expiring contracts. For example, the Tesla business in California that we have discussed in the past. With all the puts and takes, Adient's fiscal 2021 adjusted EBITDA would have been roughly $810 million adjusting for the portfolio changes versus the $917 million reported. By quarter, the $810 million would be calendarized as follows: approximately $320 million in Q1, $290 million in Q2, $125 million in Q3, and $75 million in Q4. Now walking the $810 million to our forecast for fiscal 2022. Starting with the positives. Volume although muted given the production expectations in Asia is expected to have a year-over-year benefit. Temporary compensation actions, such as suspending the company's 401(k) match in the US our e-band salaried reduction and RSU replacement program and other similar actions. Similarly our back-to-basics strategy is expected to drive further operational and cost improvements. And finally, commercial profitability actions and the impact of FX will provide much needed tailwinds. Unfortunately, offsetting these benefits are several headwinds, such as significantly elevated commodity cost, net of recoveries, which are forecast to be approximately $125 million hit year-on-year. We assume commodity prices will remain at their current levels. If prices drop, and depending when the drop occurs, this could translate into upside within our forecast. This compares favorably to the previous estimate of $200 million impact, we discussed on our last call, as our team has developed mitigation strategies to offset some of the impact. In addition, higher freight and energy costs are expected to pressure earnings. While we are actively pursuing and implementing mitigation plans, we've seen cost for freight lanes increased seven to 10 times over the last year. Mix will contribute to the downward pressure as higher-margin regions such as China and Southeast Asia are expected to experience lower volumes. Lower equity income compared to our pro forma adjusted results driven by outperformance in fiscal 2021 and the impact of net commodity costs at our unconsolidated joint ventures. Engineering and launch costs are forecast to be higher in fiscal 2022 versus 2021. Certain of this increase, is attributed to various programs being pushed from 2021 into 2022 as fiscal 2021 experienced an unusually low level of spend. Finally, certain of the benefits recognized in fiscal 2021, are not expected to repeat in 2022. One such example is the roughly $30 million of commercial settlements we called out in Q1 fiscal 2021 that we considered one-time in nature. Bottom line, when shifting through the puts and takes at this moment, we expect the headwinds to modestly outweigh the tailwinds for 2022 and to be somewhere less -- and for 2022 to be somewhere less than our pro forma 2021 results. Given the volatility around inflation inputs, the challenges around securing labor especially given the uncertainties around the impact the vaccine mandate will have and other challenges we've discussed providing more specific guidance on full year fiscal 2022 adjusted EBITDA with reasonable certainty, is not possible at this time. That said, we will continue to provide regular updates to the market as clarity hopefully returns. It's also reasonable to apply the same impact to fiscal 2022 as summarized on slide five of this presentation. The shortfall in our expected revenues due to supply constraints appears approximately consistent year-over-year as do our inefficiencies. Meanwhile, the commodity headwinds have increased a further $125 million. One final point on our fiscal 2022 EBITDA forecast, we'd expect our first quarter results to be the low watermark for the year. In fact, Q1 EBITDA is currently expected to settle at or modestly higher versus the quarter just completed after adjusting for our footprint changes. Two key reasons: first, we will experience a step up in our negotiated steel prices which took effect October 1; second, we benefited from several true-ups, as mentioned earlier, to our year-end accruals in fiscal 2021's fourth quarter such as our incentive compensation and medical accruals effectively meaning that we had over accrued in earlier quarters and true them up to actual results in Q4. We largely expect these factors to offset the benefit of slightly higher revenues in our first quarter. Now that, we've covered our fiscal 2022 expectations for sales and adjusted EBITDA, let me quickly comment on expectations for a few key financial metrics on slide 23. Starting with equity income, based on our assumptions of production in China, the portfolio actions implemented in fiscal 2021 and FX rates, we'd expect equity income to land around $80 million to $90 million. Interest expense of about $150 million, includes an assumption of a further $1 billion of principal debt prepayments in 2022. Cash taxes in fiscal 2022 are expected to be around $80 million. Our booked cash taxes are expected to be slightly higher call, it about $100 million at this time. During fiscal 2022, we might see our adjusted effective tax rate higher than normal, and fluctuations amongst quarters, due to valuation allowances and our geographic mix of income. That said, it's important to remember that, we maintain valuable tax attributes such as net operating loss carryforwards, and that these tax attributes can be used to offset profits on a going-forward basis, so cash taxes on Adient's operations, should remain relatively low even as profits increase. Capital expenditures are forecast to be about $300 million to $325 million. Just a few comments regarding the forecast, as it's elevated versus the 2021 spend. First, the majority of spend supports customer launch plans and the timing of those launches. Fiscal 2021 spend, was unusually low under 2% of sales, as certain launches were pushed into fiscal 2022. Slight uptick year-over-year is driven by the consolidation of CQ, AT&T and the Langfang entities as part of the China transaction call it around $15 million or so. As you can see at the bottom of the slide, given the backdrop of the current operating environment, providing specific full year estimates for adjusted EBITDA equity income and free cash flow with reasonable certainty is not possible at this time. With that, let's move on to the question-and-answer portion of the call. Operator, first question please.